Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 343

1.

Caveolin-1-derived peptide limits development of pulmonary fibrosis.

Marudamuthu AS, Bhandary YP, Fan L, Radhakrishnan V, MacKenzie B, Maier E, Shetty SK, Nagaraja MR, Gopu V, Tiwari N, Zhang Y, Watts AB, Williams RO 3rd, Criner GJ, Bolla S, Marchetti N, Idell S, Shetty S.

Sci Transl Med. 2019 Dec 11;11(522). pii: eaat2848. doi: 10.1126/scitranslmed.aat2848.

PMID:
31826982
2.

Evaluation of Cytogenetic Abnormalities in Patients with Acute Lymphoblastic Leukemia.

Reddy P, Shankar R, Koshy T, Radhakrishnan V, Ganesan P, Jayachandran PK, Dhanushkodi M, Mehra N, Krupashankar S, Manasa P, Nagare RP, Swaminathan R, Kannan K, Sagar TG, Ganesan TS.

Indian J Hematol Blood Transfus. 2019 Oct;35(4):640-648. doi: 10.1007/s12288-019-01123-8. Epub 2019 Apr 17.

PMID:
31741615
3.

Biosynthesis of silver nanoparticles using red algae Portieria hornemannii and its antibacterial activity against fish pathogens.

Fatima R, Priya M, Indurthi L, Radhakrishnan V, Sudhakaran R.

Microb Pathog. 2020 Jan;138:103780. doi: 10.1016/j.micpath.2019.103780. Epub 2019 Oct 14.

PMID:
31622663
4.

Gemcitabine, vinorelbine and dexamethasone: A safe and effective regimen for treatment of relapsed/refractory hodgkin's lymphoma.

Ganesan P, Mehra N, Joel A, Radhakrishnan V, Dhanushkodi M, Perumal Kalayarasi J, Kannan K, Ganesan TS, Sagar TG.

Leuk Res. 2019 Sep;84:106188. doi: 10.1016/j.leukres.2019.106188. Epub 2019 Jul 11.

PMID:
31325732
5.

Evaluation of in silico designed inhibitors targeting MelF (Rv1936) against Mycobacterium marinum within macrophages.

Dharra R, Radhakrishnan VS, Prasad T, Thakur Z, Cirillo JD, Sheoran A, Pandey AK, Kulharia M, Mehta PK.

Sci Rep. 2019 Jul 12;9(1):10084. doi: 10.1038/s41598-019-46295-5.

6.

CD19 negative and dim precursor B-lineage acute lymphoblastic leukemias: real-world challenges in a targeted-immunotherapy era.

Bommannan BKK, Arumugam JR, Sundersingh S, Rajan PT, Radhakrishnan V, Sagar TG.

Leuk Lymphoma. 2019 Dec;60(13):3154-3160. doi: 10.1080/10428194.2019.1625043. Epub 2019 Jun 11.

PMID:
31184238
7.

Ethics of cancer care: beyond biology and medicine.

Ghose S, Radhakrishnan V, Bhattacharya S.

Ecancermedicalscience. 2019 Mar 28;13:911. doi: 10.3332/ecancer.2019.911. eCollection 2019. Review.

8.

Health issues in a Bangalore slum: findings from a household survey using a mobile screening toolkit in Devarajeevanahalli.

George CE, Norman G, Wadugodapitya A, Rao SV, Nalige S, Radhakrishnan V, Behar S, de Witte L.

BMC Public Health. 2019 Apr 29;19(1):456. doi: 10.1186/s12889-019-6756-7.

9.

Outcomes of Intensive Treatment of Adult Acute Myeloid Leukemia Patients: A Retrospective Study From a Single Centre.

Kalaiyarasi JP, Ganesan P, Kannan K, Ganesan TS, Radhakrishnan V, Dhanushkodi M, Krupashankar S, Mehra N, Sagar TG.

Indian J Hematol Blood Transfus. 2019 Apr;35(2):248-254. doi: 10.1007/s12288-018-1023-0. Epub 2018 Oct 1.

PMID:
30988559
10.

Neoadjuvant concurrent chemoradiation in male breast cancer: Experience from a tertiary cancer center.

Iyer P, Balasubramanian A, Selvaluxmy G, Sridevi V, Krishnamurthy A, Radhakrishnan V.

Indian J Cancer. 2019 Jan-Mar;56(1):37-40. doi: 10.4103/ijc.IJC_44_18.

11.

Spectrum and Immunophenotypic Profile of Acute Leukemia: A Tertiary Center Flow Cytometry Experience.

Gupta N, Pawar R, Banerjee S, Brahma S, Rath A, Shewale S, Parihar M, Singh M, Arun SR, Krishnan S, Bhatacharyya A, Das A, Kumar J, Bhave S, Radhakrishnan V, Nair R, Chandy M, Arora N, Mishra D.

Mediterr J Hematol Infect Dis. 2019 Mar 1;11(1):e2019017. doi: 10.4084/MJHID.2019.017. eCollection 2019.

12.

MYD88 and CXCR4 Mutation Profiling in Lymphoplasmacytic Lymphoma/Waldenstrom's Macroglobulinaemia.

Vinarkar S, Arora N, Chowdhury SS, Saha K, Pal B, Parihar M, Radhakrishnan VS, Chakrapani A, Bhartia S, Bhave S, Chandy M, Nair R, Mishra DK.

Indian J Hematol Blood Transfus. 2019 Jan;35(1):57-65. doi: 10.1007/s12288-018-0978-1. Epub 2018 Jul 2.

13.

Outcomes of Oral Metronomic Therapy in Patients with Lymphomas.

Mailankody S, Ganesan P, Joshi A, Ganesan TS, Radhakrishnan V, Dhanushkodi M, Mehra N, Kalaiyarasi JP, Kannan K, Sagar TG.

Indian J Hematol Blood Transfus. 2019 Jan;35(1):50-56. doi: 10.1007/s12288-018-0995-0. Epub 2018 Aug 2.

14.

Chronic Myeloid Leukemia: Long-Term Outcome Data in the Imatinib Era.

Ganesan P, Ganesan TS, Radhakrishnan V, Sagar TG, Kannan K, Dhanushkodi M, Kalayarasi JP, Mehra N.

Indian J Hematol Blood Transfus. 2019 Jan;35(1):37-42. doi: 10.1007/s12288-018-1009-y. Epub 2018 Sep 8.

15.

Real World Experience of Treating Neuroblastoma: Experience from a Tertiary Cancer Centre in India.

Radhakrishnan V, Raja A, Dhanushkodi M, Ganesan TS, Selvaluxmy G, Sagar TG.

Indian J Pediatr. 2019 May;86(5):417-426. doi: 10.1007/s12098-018-2834-6. Epub 2019 Feb 18.

PMID:
30778950
16.

Factors that impact the outcomes in testicular germ cell tumors in low-middle-income countries.

Saju SV, Radhakrishnan V, Ganesan TS, Dhanushkodi M, Raja A, Selvaluxmy G, Sagar TG.

Med Oncol. 2019 Feb 6;36(3):28. doi: 10.1007/s12032-019-1252-6.

PMID:
30725328
17.

FxCycle™ Based Ploidy Correlates with Cytogenetic Ploidy in B-Cell Acute Lymphoblastic Leukemia and Is Able to Detect the Aneuploid Minimal Residual Disease Clone.

Gupta N, Parihar M, Banerjee S, Brahma S, Pawar R, Rath A, Shewale S, Singh M, Sasikumaran Nair Remani A, Krishnan S, Bhatacharyya A, Das A, Kumar J, Bhave S, Radhakrishnan V, Nair R, Chandy M, Mishra D, Arora N.

Cytometry B Clin Cytom. 2019 Sep;96(5):359-367. doi: 10.1002/cyto.b.21765. Epub 2019 Feb 4.

PMID:
30715800
18.

Cell Cycle Arrest and Cytotoxic Effects of SAHA and RG7388 Mediated through p21WAF1/CIP1 and p27KIP1 in Cancer Cells.

Natarajan U, Venkatesan T, Radhakrishnan V, Samuel S, Rasappan P, Rathinavelu A.

Medicina (Kaunas). 2019 Jan 29;55(2). pii: E30. doi: 10.3390/medicina55020030.

19.

Gastrointestinal mucormycosis in a child with acute lymphoblastic leukemia: An uncommon but ominous complication.

Totadri S, Sundersingh S, Natarajan R, Seshadri RA, Radhakrishnan V.

Indian J Cancer. 2018 Jul-Sep;55(3):304-305. doi: 10.4103/ijc.IJC_260_18.

20.

Detection of Mycobacterium tuberculosis purified ESAT-6 (Rv3875) by magnetic bead-coupled gold nanoparticle-based immuno-PCR assay.

Singh N, Dahiya B, Radhakrishnan VS, Prasad T, Mehta PK.

Int J Nanomedicine. 2018 Dec 12;13:8523-8535. doi: 10.2147/IJN.S181052. eCollection 2018.

21.

Differential Mechanisms of Cell Death Induced by HDAC Inhibitor SAHA and MDM2 Inhibitor RG7388 in MCF-7 Cells.

Natarajan U, Venkatesan T, Radhakrishnan V, Samuel S, Rathinavelu A.

Cells. 2018 Dec 22;8(1). pii: E8. doi: 10.3390/cells8010008.

22.

Prognostic Utility of the IPS 3 Score for Predicting Outcomes in Advanced Hodgkin Lymphoma.

Ganesan P, Dhanushkodi M, Ganesan TS, Radhakrishnan V, Kannan K, Sundersingh S, Sagar TG.

Clin Lymphoma Myeloma Leuk. 2019 Feb;19(2):116-122. doi: 10.1016/j.clml.2018.11.009. Epub 2018 Nov 13.

PMID:
30579722
23.

Intravenous fosaprepitant for the prevention of chemotherapy-induced vomiting in children: A double-blind, placebo-controlled, phase III randomized trial.

Radhakrishnan V, Joshi A, Ramamoorthy J, Rajaraman S, Ganesan P, Ganesan TS, Dhanushkodi M, Sagar TG.

Pediatr Blood Cancer. 2019 Mar;66(3):e27551. doi: 10.1002/pbc.27551. Epub 2018 Nov 13.

PMID:
30426714
24.

Corrigendum to "Expression of Intratumoral IGF-II Is Regulated by the Gene Imprinting Status in Triple Negative Breast Cancer from Vietnamese Patients".

Radhakrishnan VK, Hernandez LC, Anderson K, Tan Q, De León M, De León DD.

Int J Endocrinol. 2018 Oct 23;2018:8434297. doi: 10.1155/2018/8434297. eCollection 2018.

25.

Efficacy of Single Dose Rasburicase (1.5 mg) for Prophylaxis and Management of Laboratory Tumor Lysis Syndrome.

Philips A, Radhakrishnan V, Ganesan P, Ganesan TS, Ramamurthy J, Dhanushkodi M, Sagar TG.

Indian J Hematol Blood Transfus. 2018 Oct;34(4):618-622. doi: 10.1007/s12288-018-0938-9. Epub 2018 Mar 3.

26.

The East-West late lumen loss study: Comparison of angiographic late lumen loss between Eastern and Western drug-eluting stent study cohorts.

Harrison RW, Radhakrishnan V, Allen JC Jr, Lam PS, Allocco DJ, Brar S, Fahy M, Zhang Z, Fisher R, Ikeno F, Généreux P, Kimura T, Liu M, Lye WK, Nagai H, Suzuki Y, White R, Krucoff MW.

Am Heart J. 2018 Dec;206:61-71. doi: 10.1016/j.ahj.2018.08.017. Epub 2018 Sep 7.

PMID:
30342296
27.

p53 Expression in Lung Fibroblasts Is Linked to Mitigation of Fibrotic Lung Remodeling.

Nagaraja MR, Tiwari N, Shetty SK, Marudamuthu AS, Fan L, Ostrom RS, Fu J, Gopu V, Radhakrishnan V, Idell S, Shetty S.

Am J Pathol. 2018 Oct;188(10):2207-2222. doi: 10.1016/j.ajpath.2018.07.005.

28.

Can Radiotherapy Be Omitted in Children With Hodgkin Lymphoma Who Achieve Metabolic Remission on Interim Positron Emission Tomography? Experience of a Tertiary Care Cancer Referral Center.

Totadri S, Radhakrishnan V, Ganesan TS, Ganesan P, Kannan K, Lakshmipathy KM, Selvaluxmy G, Sagar TG.

J Glob Oncol. 2018 Sep;4:1-7. doi: 10.1200/JGO.2017.009340. Epub 2017 Aug 4.

29.

DA-EPOCH-R in Aggressive CD 20 Positive B Cell Lymphomas: Real-World Experience.

Ganesan P, Ganesan TS, Atreya H, Kannan K, Radhakrishnan V, Dhanushkodi M, Joshua TLA, Sundersingh S, Sagar TG.

Indian J Hematol Blood Transfus. 2018 Jul;34(3):454-459. doi: 10.1007/s12288-017-0901-1. Epub 2017 Nov 4.

30.

Experience with the Use of Nilotinib in Indian Patients.

Manuprasad A, Ganesan P, Ganesan TS, Radhakrishnan V, Dhanushkodi M, Mani S, Sagar TG.

Indian J Hematol Blood Transfus. 2018 Jul;34(3):443-447. doi: 10.1007/s12288-017-0877-x. Epub 2017 Oct 7.

31.

Acute Lymphoblastic Leukemia in Young Adults Treated with Intensive "Pediatric" Type Protocol.

Ganesan P, Sagar TG, Kannan K, Radhakrishnan V, Dhanushkodi M, Swaminathan R, Sundersingh S, Ganesan TS.

Indian J Hematol Blood Transfus. 2018 Jul;34(3):422-429. doi: 10.1007/s12288-017-0892-y. Epub 2017 Oct 17.

32.

Management of Lymphomas: Consensus Document 2018 by an Indian Expert Group.

Nair R, Kakroo A, Bapna A, Gogia A, Vora A, Pathak A, Korula A, Chakrapani A, Doval D, Prakash G, Biswas G, Menon H, Bhattacharya M, Chandy M, Parihar M, Vamshi Krishna M, Arora N, Gadhyalpatil N, Malhotra P, Narayanan P, Nair R, Basu R, Shah S, Bhave S, Bondarde S, Bhartiya S, Nityanand S, Gujral S, Tilak TVS, Radhakrishnan V.

Indian J Hematol Blood Transfus. 2018 Jul;34(3):398-421. doi: 10.1007/s12288-018-0991-4. Epub 2018 Aug 3. Review.

33.

Neoadjuvant chemoradiation for locally advanced resectable carcinoma of the esophagus: A single-center experience from India with a brief review of the literature.

Krishnamurthy A, Mohanraj N, Radhakrishnan V, John A, Selvaluxmy G.

Indian J Cancer. 2017 Oct-Dec;54(4):646-651. doi: 10.4103/ijc.IJC_452_17.

34.

pH-modulated self-assembly of colloidal nanoparticles in a dual-droplet inkjet printing process.

Al-Milaji KN, Radhakrishnan V, Kamerkar P, Zhao H.

J Colloid Interface Sci. 2018 Nov 1;529:234-242. doi: 10.1016/j.jcis.2018.06.008. Epub 2018 Jun 5.

PMID:
29894941
35.

Silver nanoparticles induced alterations in multiple cellular targets, which are critical for drug susceptibilities and pathogenicity in fungal pathogen (Candida albicans).

Radhakrishnan VS, Reddy Mudiam MK, Kumar M, Dwivedi SP, Singh SP, Prasad T.

Int J Nanomedicine. 2018 May 3;13:2647-2663. doi: 10.2147/IJN.S150648. eCollection 2018.

36.

Cytomegalovirus reactivation and disease amongst patients with allogeneic haematopoietic stem cell transplantation in Eastern India: Epidemiology, outcome and healthcare cost.

Kumar M, Roychowdhury M, Kumar J, Harishankar A, Sinha S, Bhave SJ, Chakrapani A, Radhakrishnan V, Nair R, Bhattacharya S, Chandy M.

Indian J Med Microbiol. 2018 Jan-Mar;36(1):49-53. doi: 10.4103/ijmm.IJMM_17_269.

37.

In vitro studies on oxidative stress-independent, Ag nanoparticles-induced cell toxicity of Candida albicans, an opportunistic pathogen.

Radhakrishnan VS, Dwivedi SP, Siddiqui MH, Prasad T.

Int J Nanomedicine. 2018 Mar 15;13(T-NANO 2014 Abstracts):91-96. doi: 10.2147/IJN.S125010. eCollection 2018.

38.

A Magna Carta in psychosocial rehabilitation: The long road traveled.

Radhakrishnan VK, Abraham KR.

Indian J Psychiatry. 2017 Oct-Dec;59(4):407-410. doi: 10.4103/psychiatry.IndianJPsychiatry_206_17. No abstract available.

39.

Long-term outcome of diffuse large B-cell lymphoma: Impact of biosimilar rituximab and radiation.

Ganesan P, Sagar TG, Kannan K, Radhakrishnan V, Rajaraman S, John A, Sundersingh S, Mahajan V, Ganesan TS.

Indian J Cancer. 2017 Apr-Jun;54(2):430-435. doi: 10.4103/ijc.IJC_241_17.

40.

Angiographic predictors of success in antegrade approach of Chronic Total Occlusion interventions in a South Indian population in the contemporary era.

Ks G, Iype M, Viswanathan S, Koshy AG, Gupta PN, Sivaprasad K, Radhakrishnan VV.

Indian Heart J. 2018 Jan - Feb;70(1):15-19. doi: 10.1016/j.ihj.2017.09.002. Epub 2017 Sep 8.

41.

Effectiveness of olanzapine in patients who fail therapy with aprepitant while receiving highly emetogenic chemotherapy.

Mehra N, Ganesan P, Ganesan TS, Veeriah S, Boopathy A, Radhakrishnan V, Dhanushkodi M, Rajaraman S, Ganesharajah S, Sagar TG.

Med Oncol. 2017 Dec 16;35(1):12. doi: 10.1007/s12032-017-1074-3.

PMID:
29248965
42.

Initial experiences with NAM-assisted primary repair of the BCLP deformity.

Prasad S, Ravindran S, Radhakrishnan V, Hazarey PV, Vanka A, Rajan B.

Spec Care Dentist. 2017 Nov;37(6):304-308. doi: 10.1111/scd.12252. Epub 2017 Dec 1.

PMID:
29194721
43.

Pediatric Hodgkin Lymphoma Treated at Cancer Institute, Chennai, India: Long-Term Outcome.

Radhakrishnan V, Dhanushkodi M, Ganesan TS, Ganesan P, Sundersingh S, Selvaluxmy G, Swaminathan R, Rama R, Sagar TG.

J Glob Oncol. 2016 Nov 9;3(5):545-554. doi: 10.1200/JGO.2016.005314. eCollection 2017 Oct.

44.

Outcomes in Lung Cancer: 9-Year Experience From a Tertiary Cancer Center in India.

Murali AN, Radhakrishnan V, Ganesan TS, Rajendranath R, Ganesan P, Selvaluxmy G, Swaminathan R, Sundersingh S, Krishnamurthy A, Sagar TG.

J Glob Oncol. 2017 Jan 11;3(5):459-468. doi: 10.1200/JGO.2016.006676. eCollection 2017 Oct.

45.

Predictors of Chemotherapy Related Toxicities in Elderly Lymphoma Patients: Experience from a Tertiary Cancer Centre.

Mishra S, Radhakrishnan V, Ganesan P, Rajendranath R, Rajaraman S, Ganesan TS, Sagar TG.

Indian J Hematol Blood Transfus. 2017 Dec;33(4):470-476. doi: 10.1007/s12288-017-0794-z. Epub 2017 Feb 25.

46.

Prevalence of multi-drug resistant organisms in stool of paediatric patients with acute leukaemia and correlation with blood culture positivity: A single institution experience.

Shankar K, Radhakrishnan V, Vijayakumar V, Ramamoorthy J, Ganesan P, Dhanushkodi M, Ganesan TS, Sagar TG.

Pediatr Blood Cancer. 2018 Jan;65(1). doi: 10.1002/pbc.26740. Epub 2017 Aug 2.

PMID:
28766888
47.

Lomustine induced acute pulmonary toxicity in a pediatric medulloblastoma survivor.

Radhakrishnan V, Perumal J, Sundersingh S, Sagar T.

South Asian J Cancer. 2017 Jan-Mar;6(1):38-39. doi: 10.4103/2278-330X.202570. No abstract available.

48.

Diagnosis and Management of Rhabdomyosarcoma in Children and Adolescents: ICMR Consensus Document.

Panda SP, Chinnaswamy G, Vora T, Prasad M, Bansal D, Kapoor G, Radhakrishnan V, Agarwala S, Laskar S, Arora B, Kaur T, Rath GK, Bakhshi S.

Indian J Pediatr. 2017 May;84(5):393-402. doi: 10.1007/s12098-017-2315-3. Epub 2017 Apr 5. Review.

PMID:
28378141
49.

Management of Non-Hodgkin Lymphoma: ICMR Consensus Document.

Thacker N, Bakhshi S, Chinnaswamy G, Vora T, Prasad M, Bansal D, Agarwala S, Kapoor G, Radhakrishnan V, Laskar S, Kaur T, Rath GK, Dhaliwal RS, Arora B.

Indian J Pediatr. 2017 May;84(5):382-392. doi: 10.1007/s12098-017-2318-0. Epub 2017 Apr 5. Review.

PMID:
28378140
50.

Management of Neuroblastoma: ICMR Consensus Document.

Bansal D, Totadri S, Chinnaswamy G, Agarwala S, Vora T, Arora B, Prasad M, Kapoor G, Radhakrishnan V, Laskar S, Kaur T, Rath GK, Bakhshi S.

Indian J Pediatr. 2017 Jun;84(6):446-455. doi: 10.1007/s12098-017-2298-0. Epub 2017 Apr 3. Review.

PMID:
28367616

Supplemental Content

Loading ...
Support Center